A股異動 | 華力創通(300045.SZ)大漲近16% 子公司成功研製出北斗三號高精度定位核心基帶芯片
格隆匯7月15日丨華力創通(300045.SZ)高開高走,現漲幅擴大至近16%,報11.25元,總市值69億元。

華力創通昨日宣佈,其全資子公司華力智芯(成都)集成電路有限公司,近期成功研製出“北斗三號高精度定位 SoC 核心基帶芯片 HTG001”,該產品為華力智芯自主研發的適用於北斗三號導航系統的高精度基帶芯片,標誌着公司衞星應用產業化又迎來重大突破。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.